Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Blood Cancer Journal|June 24, 2021
AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemiaWaqas Nawaz, Bilian Huang, Shijie Xu, et al.
Thrombosis and Haemostasis|June 10, 2011
Platelets regulate CD4⁺ T-cell differentiation via multiple chemokines in humansNorbert Gerdes, Linjing Zhu, Maria Ersoy, et al.
Pest Management Science|July 9, 2021
Synthesis of a series of validoxylamine A esters and their biological activitiesYuele Lu, Kang Ye, Linjing Zhu, et al.
Blood|February 19, 2011
Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuliMadhumita Chatterjee, Zhangsen Huang, Wei Zhang, et al.
JCI Insight|July 10, 2020
A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivoXilin Wu, Yanlei Li, Bilian Huang, et al.
Frontiers in Immunology|July 12, 2021
Potent Neutralizing Humanized Antibody With Topical Therapeutic Potential Against HPV18-Related Cervical CancerBilian Huang, Linjing Zhu, Hongxia Wei, et al.
Communications Biology|February 20, 2025
mGluR5-mediated astrocytes hyperactivity in the anterior cingulate cortex contributes to neuropathic pain in male miceWeida Shen, Fujian Chen, Yejiao Tang, et al.
EMBO Reports|August 11, 2025
sVEGFR1 up-regulation via EGR1 impairs vascular repair in SFTSV-induced hemorrhageNa Jiang, Jing Wu, Yating He, et al.
Cell Reports|October 13, 2021
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administrationXilin Wu, Lin Cheng, Ming Fu, et al.
Frontiers in Immunology|April 4, 2022
Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22)Xilin Wu, Yaxing Wang, Lin Cheng, et al.
Pageof 3